OVARIAN ENDOMETRIOID TUMOR
Clinical trials for OVARIAN ENDOMETRIOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN ENDOMETRIOID TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN ENDOMETRIOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill vs. IV drip: major trial tests easier treatment for returning ovarian cancer
Disease control OngoingThis large, late-stage trial is testing whether taking pills (olaparib alone or with cediranib) works as well or better than standard intravenous chemotherapy for women whose ovarian, fallopian tube, or primary peritoneal cancer has returned but still responds to platinum drugs. …
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for recurrent ovarian cancer? early trial tests drug to boost chemo
Disease control OngoingThis early-stage study is testing whether adding an experimental drug called berzosertib (M6620) to standard chemotherapy (carboplatin and gemcitabine) is safe and might work better for women whose ovarian, fallopian tube, or primary peritoneal cancer has returned. The main goal …
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC